Literature DB >> 23064787

Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.

Hui Liu1, Gang Chen, Wei Zhang, Jun-Yi Zhu, Zhao-Quan Lin, Zhong-Cheng Gong, Feng-Qin Wang, Jun Jia, Zhi-Jun Sun, Yi-Fang Zhao.   

Abstract

OBJECTIVES: Adenoid cystic carcinoma (ACC) is a malignant tumor frequently arising in salivary glands with poor long-term prognosis due to high rates of local recurrences and distant metastases. Macrophage migration inhibitory factor (MIF) is a multi-functional cytokine and has recently emerged as a pro-tumorigenic factor in various cancers. This study is designed to investigate the expression status and functional significance of MIF in ACC.
METHODS: Immunohistochemical staining was performed to evaluate the expression levels of MIF, HIF-1α, MMP-9, p53, and p-JNK in ACC tissues. In vitro, ACC-2 cells were exposed to recombinant human MIF (rMIF) or ISO-1 (an inhibitor of MIF) at different concentrations and times, followed by the detection of cell growth, viability, migration, and invasion, as well as the expression levels of several cellular signals.
RESULTS: The immunohistochemical results demonstrated the overexpression of MIF in ACC tissues as well as its association with the distant metastasis. Further analyses showed a significant correlation between the staining of MIF and p-JNK. Moreover, the in vitro studies revealed that the treatment for ACC cells with ISO-1 significantly attenuated cell migratory and invasive capacity, as opposed to the limited promotive effects of rMIF. More importantly, MIF inhibition could cause the activation of JNK, correlating with the immunohistochemical findings on ACC tissues.
CONCLUSIONS: The results suggest that MIF is likely to be an important player in the pathogenesis of ACC and may promote cancer metastasis, which possibly involves JNK inactivation. Further investigation of MIF-mediated molecular events may provide novel insights into the treatment for ACC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064787     DOI: 10.1007/s00432-012-1330-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer.

Authors:  Majid Nabizadeh Marvast; Hamid Reza Sima; Kamran Ghaffarzadehgan; Ali Taghizadeh Kermani; Nona Norouzi
Journal:  J Gastrointest Cancer       Date:  2011-03

Review 2.  Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.

Authors:  R L Dodd; N J Slevin
Journal:  Oral Oncol       Date:  2006-06-06       Impact factor: 5.337

3.  Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.

Authors:  Zhi-Jun Sun; Gang Chen; Xiang Hu; Wei Zhang; Yang Liu; Ling-Xin Zhu; Qian Zhou; Yi-Fang Zhao
Journal:  Apoptosis       Date:  2010-07       Impact factor: 4.677

4.  Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.

Authors:  Songlin Piao; Shu Zhao; Fulin Guo; Jie Xue; Guodong Yao; Zhili Wei; Qi Huang; Yao Sun; Bin Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-04       Impact factor: 4.553

5.  Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma.

Authors:  Yaling Tang; Xinhua Liang; Min Zheng; Zhiyu Zhu; Guiquan Zhu; Jing Yang; Yu Chen
Journal:  Oral Oncol       Date:  2010-03-09       Impact factor: 5.337

6.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.

Authors:  R Kleemann; A Hausser; G Geiger; R Mischke; A Burger-Kentischer; O Flieger; F J Johannes; T Roger; T Calandra; A Kapurniotu; M Grell; D Finkelmeier; H Brunner; J Bernhagen
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

7.  Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.

Authors:  Zhi-Jun Sun; Gang Chen; Wei Zhang; Xiang Hu; Yang Liu; Qian Zhou; Ling-Xing Zhu; Yi-Fang Zhao
Journal:  Mol Pharmacol       Date:  2010-10-19       Impact factor: 4.436

8.  Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma.

Authors:  Congfa Huang; Zhijun Sun; Yan Sun; Xinming Chen; Xiaojie Zhu; Chengchao Fan; Bing Liu; Yifang Zhao; Wenfeng Zhang
Journal:  Histopathology       Date:  2012-02-09       Impact factor: 5.087

9.  Novel derivatives of ISO-1 as potent inhibitors of MIF biological function.

Authors:  Sarala Balachandran; Atish Rodge; Pradip K Gadekar; Vitthal N Yadav; Divya Kamath; Anshu Chetrapal-Kunwar; Pooja Bhatt; Shaila Srinivasan; Somesh Sharma; Ram A Vishwakarma; Nilesh M Dagia
Journal:  Bioorg Med Chem Lett       Date:  2009-06-17       Impact factor: 2.823

Review 10.  Cell surface association of matrix metalloproteinase-9 (gelatinase B).

Authors:  Rafael Fridman; Marta Toth; Irina Chvyrkova; Samy O Meroueh; Shahriar Mobashery
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

View more
  11 in total

1.  HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT.

Authors:  Yang Liu; Yawei Liu; Xiaolu Yan; Yuan Xu; Fei Luo; Jing Ye; Han Yan; Xiaojun Yang; Xiaodan Huang; Jianping Zhang; Guozhong Ji
Journal:  Tumour Biol       Date:  2014-05-20

2.  Expression of macrophage migration inhibitory factor in the mouse neocortex and posterior piriform cortices during postnatal development.

Authors:  Wei Zhang; Lingling Li; Jiutao Wang; Lei An; Xinde Hu; Jiongfang Xie; Runchuan Yan; Shulin Chen; Shanting Zhao
Journal:  Cell Mol Neurobiol       Date:  2014-08-14       Impact factor: 5.046

3.  Longitudinal assessment of spinal cord injuries in nonhuman primates with quantitative magnetization transfer.

Authors:  Feng Wang; Ke Li; Arabinda Mishra; Daniel Gochberg; Li Min Chen; John C Gore
Journal:  Magn Reson Med       Date:  2015-05-08       Impact factor: 4.668

4.  Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets.

Authors:  Nadège Kindt; Fabrice Journe; Guy Laurent; Sven Saussez
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

Review 5.  Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.

Authors:  Sha-Sha Wang; Xiao Cen; Xin-Hua Liang; Ya-Ling Tang
Journal:  Oncotarget       Date:  2017-02-07

6.  Expression of MIF, Beclin1, and LC3 in human salivary gland adenoid cystic carcinoma and its prognostic value.

Authors:  Chenxi Li; Qingli Chen; Zhongqi Tian; Shixiao Li; Zhongcheng Gong; Zhaoquan Lin; Bing Wang; Hui Liu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma.

Authors:  Yu-Fan Wang; Wei Zhang; Ke-Fei He; Bing Liu; Lu Zhang; Wen-Feng Zhang; Ashok B Kulkarni; Yi-Fang Zhao; Zhi-Jun Sun
Journal:  Apoptosis       Date:  2014-04       Impact factor: 5.561

8.  Macrophage migration inhibitory factor and stearoyl-CoA desaturase 1: potential prognostic markers for soft tissue sarcomas based on bioinformatics analyses.

Authors:  Hiro Takahashi; Robert Nakayama; Shuhei Hayashi; Takeshi Nemoto; Yasuyuki Murase; Koji Nomura; Teruyoshi Takahashi; Kenji Kubo; Shigetaka Marui; Koji Yasuhara; Tetsuro Nakamura; Takuya Sueo; Anna Takahashi; Kaname Tsutsumiuchi; Tsutomu Ohta; Akira Kawai; Shintaro Sugita; Shinjiro Yamamoto; Takeshi Kobayashi; Hiroyuki Honda; Teruhiko Yoshida; Tadashi Hasegawa
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

9.  Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma.

Authors:  Mariana Barbosa DE Souza; Otávio Alberto Curioni; Jossi Ledo Kanda; Marcos Brasilino DE Carvalho
Journal:  Oncol Lett       Date:  2014-09-09       Impact factor: 2.967

10.  Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.

Authors:  Tejaswini Subbannayya; Pamela Leal-Rojas; Mustafa A Barbhuiya; Remya Raja; Santosh Renuse; Gajanan Sathe; Sneha M Pinto; Nazia Syed; Vishalakshi Nanjappa; Arun H Patil; Patricia Garcia; Nandini A Sahasrabuddhe; Bipin Nair; Rafael Guerrero-Preston; Sanjay Navani; Pramod K Tiwari; Vani Santosh; David Sidransky; T S Keshava Prasad; Harsha Gowda; Juan Carlos Roa; Akhilesh Pandey; Aditi Chatterjee
Journal:  BMC Cancer       Date:  2015-11-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.